NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Ovarian Cancer



Blocking COX-1 slows tumor growth in mice



May 26th, 2005

Blocking the COX-1 enzyme - not COX-2 - might lead to a way to prevent and treat the most common and fatal form of ovarian cancer, researchers at Vanderbilt University Medical Center report.

"The finding that COX-1 inhibition slowed the growth of epithelial ovarian tumors in a mouse model of the disease is surprising," said Sudhansu K. Dey, PhD, senior author of the paper and director of the Division of Reproductive and Developmental Biology in the Vanderbilt Department of Pediatrics.

Previous studies have linked high levels of another cyclooxygenase enzyme, COX-2, to colorectal and other cancers.

"But this is the exception," said...


Source: Women's Health Weekly (2005-05-26)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login